Nicole Brinkley
Family · Manchester, TNNPI 1770651093
Payments from drug & device makers
Across 252 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$715
- GSK$261
- AstraZeneca$237
- Astellas Pharma US Inc$175
- Otsuka America Pharmaceutical, Inc.$145
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,044100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 86 | $1,186 |
| AbbVie(2 entities) | 47 | $715 |
| GSK | 13 | $261 |
| AstraZeneca | 8 | $237 |
| Astellas Pharma US Inc | 10 | $175 |
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| Xeris Pharmaceuticals, Inc. | 8 | $140 |
| Lilly USA, LLC | 8 | $132 |
| Pfizer | 7 | $122 |
| Novartis | 7 | $118 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $114 |
| Boehringer Ingelheim | 7 | $107 |
| Abbott | 6 | $100 |
| Bayer | 5 | $80 |
| Merck | 5 | $67 |
| Dexcom, Inc. | 3 | $44 |
| Gilead | 2 | $42 |
| Amgen | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,044 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 50 | $80,980 |
| JardianceEmpagliflozin | 77 | $80,332 |
| OzempicSemaglutide | 53 | $78,730 |
| JanuviaSitagliptin Phosphate | 71 | $69,567 |
| FarxigaDapagliflozin Propanediol | 78 | $68,432 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $48,226 |
| EliquisApixaban | 38 | $42,530 |
| XareltoRivaroxaban | 40 | $38,951 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 43 | $35,420 |
| Tresiba Flextouch U-200Insulin Degludec | 36 | $28,651 |
| KerendiaFinerenone | 25 | $23,322 |
| MyrbetriqMirabegron | 18 | $17,932 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $14,546 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 13 | $13,274 |
| TradjentaLinagliptin | 15 | $12,708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $1,186 | $159,710103 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $237 | $111,406139 claims |
| Boehringer IngelheimJardiance, Tradjenta | $107 | $93,03992 claims |
| MerckJanuvia | $67 | $69,56771 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $261 | $59,96880 claims |
| PfizerEliquis | $122 | $42,53038 claims |
| BayerKerendia | $80 | $23,32225 claims |
| Astellas Pharma US IncMyrbetriq | $175 | $17,93218 claims |
| AbbVieLinzess | $715 | $11,87417 claims |
| NovartisEntresto | $118 | $8,02611 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $33 | $6,95612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Manchester
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.